Next generation sequencing

Cancer immuno-oncology
#AI / data analytics / healthtech / informatics #Bispecific Antibodies #Bispecific therapeutics #Cambridge Healthtech Institute #Cancer immunotherapy #Events #Immuno-oncology #Next generation sequencing

Immuno-Oncology Summit Europe 2023: Programme highlights 

From June 20-22, 2023, Cambridge Healthtech Institute hosted the seventh annual Immuno-Oncology Summit Europe in London. DDW’s Megan Thomas shares highlights from the event programmes.   Programmes   This year’s summit was made up of conference programmes, which included: Modulating the Tumour Microenvironment; Next-Generation Cell-Based Immunotherapies; Bispecific and Multi-Specific Antibody Therapeutics, and… Read More

#Cancer Research #Exclusive Content #Opinion

#Biopharmaceuticals #Immunology / Virology & Vaccines #Investment #invoX Pharma #mRNA #mRNA-based vaccines #Next generation sequencing #Sino Biopharmaceutical

pHion to progress its lead program into the clinic 

invoX Pharma, a UK-based wholly-owned subsidiary of Sino Biopharmaceutical, with an advancing pipeline of innovative products, has completed a second tranche of investment in pHion Therapeutics, a next-generation mRNA vaccine company.   pHion is developing a pipeline of therapeutic and prophylactic vaccines focussed on oncology and infectious diseases. The company’s proprietary… Read More

#Business & Investment #News

Next-generation sequencing
#Cancer research #Genetics / genomics #Next generation sequencing #Oncology #Personalised medicine #RNA sequencing #The Tecan Group #Webinar

Free webinar today: How is NGS informing oncology drug discovery?

Join this free webinar to learn about the biggest challenges and opportunities facing the next-generation sequencing (NGS) oncology space. Hosted by DDW and supported by Tecan, “How next-generation sequencing is informing oncology drug discovery” will be free to attend at 7AM PST / 10AM EST… Read More

Webinar date:
Brought to you by Tecan
#News

Genetic sequencing in the lab
#Cancer research #Genetics / genomics #Next generation sequencing #Oncology #Personalised medicine #RNA sequencing #The Tecan Group #Webinar

Register now to learn how NGS is informing oncology drug discovery

Join this free webinar to learn about the biggest challenges and opportunities facing the next-generation sequencing (NGS) oncology space. Hosted by DDW and supported by Tecan, “How next-generation sequencing is informing oncology drug discovery” will be free to attend on April 24 at 7AM PST… Read More

Webinar date:
Brought to you by Tecan
#News

Genetic sequencing in the laboratory
#Cancer research #Genetics / genomics #Next generation sequencing #Oncology #Personalised medicine #RNA sequencing #The Tecan Group #Webinar

Webinar: Find out how NGS is informing oncology drug discovery

Join this free webinar to learn about the biggest challenges and opportunities facing the next-generation sequencing (NGS) oncology space. Hosted by DDW and supported by Tecan, “How next-generation sequencing is informing oncology drug discovery” will be free to attend on April 24 at 7AM PST… Read More

Webinar date:
Brought to you by Tecan
#News

Genetic sequencing
#Cancer research #Genetics / genomics #Next generation sequencing #Oncology #Personalised medicine #RNA sequencing #The Tecan Group #Webinar

Next-generation sequencing and oncology drug discovery

Hosted by DDW and supported by Tecan, “How next-generation sequencing is informing oncology drug discovery” will be free to attend on April 24 at 7AM PST / 10AM EST / 3PM BST / 4PM CET.   Join this free webinar to learn about the… Read More

Webinar date:
Brought to you by Tecan
#News

Genetic sequencing
#Cancer research #Genetics / genomics #Next generation sequencing #Oncology #Personalised medicine #RNA sequencing #The Tecan Group

How next-generation sequencing is informing oncology drug discovery

Watch this free webinar to learn about the biggest challenges and opportunities facing the NGS oncology space.   You will hear from Darrell Green, a lecturer in RNA Biology at Norwich Medical School, Panna Sharma, CEO of Lantern Pharma, as well as Dr Stephane Budel and Dr… Read More

Webinar date:
Brought to you by Tecan
#Webinars

#Assays #Biotechnology #DNA #Next generation sequencing #Research

Key acquisition for next generation sequencing research assays

Integrated DNA Technologies has purchased next generation sequencing (NGS) research assays from Invitae Corporation under the trademarked name Archer.   The integration of IDT’s portfolio with the acquired NGS research assays—which have been foundational in researching novel cancer fusions—will empower labs with a solution to uncover biomarkers and… Read More

#News

Laboratory studies student
#Genomics #Laboratory #Next generation sequencing #Undergraduate course #US

New genomics lab to offer NGS undergraduate course

A new laboratory specialising in genomics is set to open at the North Carolina Research Campus (NCRC) in Kannapolis, North Carolina. The Bill and Shari Graham Genomics Laboratory is a collaborative project from Catawba College and Eremid Genomic Services. The Lab will offer the only undergraduate next-generation DNA sequencing (NGS)… Read More

#News

Next generation sequencing
#Gene expression #Gene mutation #Next generation sequencing #RNA sequencing #Single-cell RNA sequencing

Is single-cell gene expression the next trend in next generation sequencing? 

Listen to this article on the DDW podcast: By Dr Dina Finan, PhD, Product Manager at 10x Genomics and Dr Nick Downey, PhD, NGS Collaborations Lead at Integrated DNA Technologies.  RNA sequencing has become a widely used tool that can explore the transcriptome in a seemingly endless number of applications. While bulk sequencing—or… Read More

#Editor's Choice #Exclusive Content